Showing results (701-710 of 846) with videos related to

Sort By:
Pageof 85
Diagnostics (Basel, Switzerland)|January 8, 2023
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related CirrhosisJae Seung Lee, Tae Seop Lim, Hye Won Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2009
What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South KoreaSeung Up Kim, Gi Hong Choi, Woong Kyu Han, et al.
American Journal of Clinical Oncology|July 1, 2009
Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resectionJong Won Choi, Jun Yong Park, Sang Hoon Ahn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 14, 2022
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related CirrhosisMi Na Kim, Jae Seung Lee, Hye Won Lee, et al.
Plos One|April 5, 2019
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resectionMi Young Jeon, Hye Soo Kim, Tae Seop Lim, et al.
The Korean Journal of Hepatology|December 23, 2004
[Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry]Jung Min Lee, Sang Hoon Ahn, Hye Young Chang, et al.
Apoptosis : an International Journal on Programmed Cell Death|September 19, 2013
Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in ratsDo Young Kim, Sook In Chung, Simon Weonsang Ro, et al.
Yonsei Medical Journal|May 19, 2016
The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation ParameterYoung Eun Chon, Kwang Joon Kim, Kyu Sik Jung, et al.
Cancers|September 28, 2021
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseJae Seung Lee, Dong Hyun Sinn, Soo Young Park, et al.
Gastroenterology Report|August 19, 2022
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease modelSang Hyun Seo, Da Hyun Lee, Yu Seol Lee, et al.
Pageof 85